UNITE IQ
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Jun 2022)
What this means for you
This application is over — abandoned 13 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88758052
- Mark type
- Stylized text
- Filed
- 14 Jan 2020
- Published for opposition
- 15 Sept 2020
- Abandoned
- 13 Jun 2022
- Attorney of record
- Joshua M. Gerben, Esq.
Goods and services
- Class 035 — Advertising and business services: Rental of office machinery and equipment
- Class 036 — Insurance and financial services: Rental of office space
- Class 040 — Treatment of materials: Manufacturing services for others in the fields of biological products, biopharmaceutical products, regenerative medicine products, combination biologic/device products, or viral and non-viral vectors for use in gene therapy, modified gene therapy, cell therapy, tissue engineering; Manufacturing services for others in the fields of biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
- Class 042 — Scientific and technological services: Rental of laboratory apparatus and instruments; Rental of laboratory equipment; Rental of laboratory instruments; Scientific laboratory services; Rental of laboratory facilities; Leasing of laboratories containing laboratory equipment for scientific research; Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research
Owner
- MORNING LIGHT IP, LLC, Radnor, PA, US
- MORNING LIGHT IP, LLC, Radnor, PA, US
Prosecution history
- 13 Jun 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Jun 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2021 — SOU EXTENSION 2 GRANTED
- 14 Sept 2021 — SOU EXTENSION 2 FILED
- 14 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2021 — SOU EXTENSION 1 GRANTED
- 11 Mar 2021 — SOU EXTENSION 1 FILED
- 11 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 10 Nov 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2020 — PUBLISHED FOR OPPOSITION
- 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER